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Abstract
Background: Beyond examining their overall cost-effectiveness and mechanisms of effect, it is important to understand
patient preferences for the delivery of different modes of chronic heart failure management programs (CHF-MPs). We
elicited patient preferences around the characteristics and willingness-to-pay (WTP) for a clinic or home-based CHF-MP.
Methodology/Principal Findings: A Discrete Choice Experiment was completed by a sub-set of patients (n = 91) enrolled in
the WHICH? trial comparing home versus clinic-based CHF-MP. Participants provided 5 choices between hypothetical clinic
and home-based programs varying by frequency of nurse consultations, nurse continuity, patient costs, and availability of
telephone or education support. Participants (aged 71613 yrs, 72.5% male, 25.3% NYHA class III/IV) displayed two distinct
preference classes. A latent class model of the choice data indicated 56% of participants preferred clinic delivery, access to
group CHF education classes, and lower cost programs (p,0.05). The remainder preferred home-based CHF-MPs, monthly
rather than weekly visits, and access to a phone advice service (p,0.05). Continuity of nurse contact was consistently
important. No significant association was observed between program preference and participant allocation in the parent
trial. WTP was estimated from the model and a dichotomous bidding technique. For those preferring clinic, estimated WTP
was <AU$9-20 per visit; however for those preferring home-based programs, WTP varied widely (AU$15-105).
Conclusions/Significance: Patient preferences for CHF-MPs were dichotomised between a home-based model which is
more likely to suit older patients, those who live alone, and those with a lower household income; and a clinic-based model
which is more likely to suit those who are more socially active and wealthier. To optimise the delivery of CHF-MPs, health
care services should consider their patients’ preferences when designing CHF-MPs.
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Introduction
Chronic heart failure (CHF) is a burdensome condition
associated with a high mortality rate and substantial health care
costs [1–3]. Multidisciplinary programs assisting patients and their
families to manage their CHF have been shown to improve quality
of life and survival, as well as to reduce hospital readmission rates
and the costs associated with the management of the condition [4].
Consequently, CHF management programs (CHF-MPs) are now
part of the gold-standard management of CHF following an acute
hospital admission [5].
Providing care that is consistent with patient values is a key
consideration in building a partnership between patients and
health care providers, and is an integral component of patient-
centred health care [6]. There is a substantial treatment burden
borne by CHF patients, and this is contributed to by factors
related to the provision of services to assist with the management
of CHF [7]. Further, there is large variation in the design of CHF-
MPs. One design consideration is the mode of delivery, with
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models of care including face-to-face programs delivered either at
a hospital clinic or in the patient’s own home [8]. This was the
focus of the WHICH? Trial (Which Heart failure Intervention is
most Cost-effective & consumer friendly in reducing Hospital care;
Australian New Zealand Clinical Trials Registry number
12607000069459 (http://www.anzctr.org.au) [9]. Although there
was no difference in the primary endpoint (risk of death or
unplanned hospitalisation during 18 month follow-up), the home-
based intervention arm was associated with around one third less
recurrent hospital days stay and significantly reduced total health
care expenditure [10]. However, beyond consideration of pure
cost-benefits, understanding patient perspectives, preferences and
choices for the delivery of programs for the management of CHF
is a crucial contextual factor to be considered alongside evidence
showing the clinical and cost-effectiveness of these programs;
particularly as patient preferences are likely to be a key component
in optimising program uptake [6].
Program participation, persistence and adherence to recom-
mendations are likely to be substantially greater when patients are
provided with their preferred choice for delivery of the program.
What is important in understanding preferences around disease
MPs and other healthcare interventions is the trade-offs patients
are prepared to make in order to have their preferred option.
Understanding these trade-offs provides insight in to the strength
of the preference and enables design of interventions that will
optimise the allocation and use of scarce healthcare resources.
Further, understanding how much more a patient is prepared to
pay to have their preferred choice allows us to quantify the
strength of their preference; this can be used alongside other
attributes of the program to identify the key factors of relevant
importance in any CHF-MP or other healthcare intervention.
Within the WHICH? Trial comparing a clinic versus home-
based CHF-MP [9], therefore, we prospectively aimed to elicit
patient preferences for the delivery of the two forms of face-to-face
CHF-MP, in order to identify:
1. Preferences for program characteristics including associations
with patient characteristics; and,
2. The value of home and clinic-based program delivery by
estimating patients’ willingness to pay (WTP) for their preferred
delivery mode (home or clinic).
Methods
The investigation conformed to the principles outlined in the
declaration of Helsinki. The preference study was approved as
a sub study of the parent WHICH? trial by the Human Research
Ethics Committees of the Princess Alexandra Hospital, Brisbane;
St Vincent’s Hospital, Sydney; the Queen Elizabeth Hospital,
Adelaide; and Griffith University, Queensland, Australia. All
participants were provided with an information sheet, had any
questions answered by the research nurse, and provided written
informed consent. Participation was completely voluntary, and
potential participants who declined to participate or otherwise
were eligible for all routine health care treatment and services and
were not disadvantaged in any other way by not participating in
the study.
A discrete choice experiment (DCE) was employed to assess
patient preferences for program delivery. The DCE is a choice-
based stated preference method for quantifying preferences and
has the potential to estimate the uptake of a program in
a population as well as to place an economic value on a service,
by estimating participants’ willingness to pay. The DCE has a firm
theoretical basis in random utility theory and Lancaster’s theory of
value [11–13]. Advantages of the DCE as a choice based method
that requires participants to explicitly make trade-offs between the
characteristics of a program in decision-making have led to it
being a popular method for eliciting preferences for healthcare
[14], with research demonstrating it’s potential in assessing
a patient-centred approach to service delivery [15].
Development of the DCE Instrument
A DCE instrument was designed to assess patient preferences
around the delivery of a CHF-MP. Participants were asked to
make repeated hypothetical choices between a clinic-based and
home-based program. Each program was described according to
five attributes (Table 1) which were predominantly developed
based on a qualitative study comprising semi-structured interviews
with twelve CHF patients [16]. This allows an assessment of the
relative impact of each of these attributes on the overall program
preference. Each attribute had two levels; for four attributes the
levels were generic across programs, whilst for the fifth attribute
(cost) the levels differed between the clinic and home alternatives.
The level for each attribute varied across alternative programs
according to a Dz-efficient fractional factorial experimental design,
estimated using NGENE software (version 1.0.2, 2010). This
ensured optimal statistical power for the design. The design
identified 20 choice sets. To ensure the number of choices faced by
this relatively elderly and frail population was manageable, these
were divided into 4 blocks of 5 choice sets, with participants
randomised to one of the four blocks. A sample choice set is shown
in Figure 1. In addition to the choice sets, participants were asked
to indicate their direct preference for clinic or home independent
of the program characteristics (‘‘If you could only choose clinic or
your home, which would you choose?’’), their WTP for their
preferred program (clinic or home), socio-demographic character-
istics, and their self-reported travel costs to attend a clinic at their
local hospital (even if they have never seen a nurse at the clinic).
Study Participants and Data Collection
Approximately 70% of health expenditure in Australia is funded
by the government, with the Australian Government responsible
for most community based services and State Governments
responsible for hospital and outpatient services. Whilst State
hospital services are generally provided at no cost to the patient,
approximately half of the population have private health insurance
[17] and there can be substantial out-of-pocket costs for many
community services regardless of insurance status.
Following a hospitalisation for CHF, the WHICH? trial
randomised participants to receive a CHF-MP delivered either
in their own home via an outreach program or via a specialist
CHF outpatient clinic [9]. Patients were recruited from three
major tertiary hospitals funded by State Government health
services in Australia and, as described in more detail previously
[9], care was standardised based on evidence-based elements of
multidisciplinary care [18].
The DCE instrument was administered face-to-face by research
nurses at the final WHICH? Trial follow-up appointment (12 to 18
months post enrolment) between July 2010 and March 2011. A
total of 126 consecutive trial participants due to attend their final
follow-up appointment were invited to participate. Visual aids and
cards containing the choice sets were available to support survey
administration. The survey instrument was pilot tested in the first
12 participants. Since no amendments were required to the
instrument, the data for these 12 participants was included in this
final analysis.
Patient Preferences for CHF Management Programs
PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e58347
Data Analysis
Participant characteristics were compared using the Chi2 test for
categorical and independent t-test for continuous variables. The
choice data were analysed using a latent class (LC) model
estimated using the statistical software package NLOGIT (version
4.0.1, 2007). The LC model allows preferences for program
delivery to vary between participants and an assessment of
associations between participant characteristics and preference
strength [19,20]. The LC model was specified with two classes. To
explore associations with class membership, respondent character-
istics were entered into the model one at a time; any characteristic
that (i) was significant in explaining class membership at the 10%
level and (ii) resulted in an equal or improved fit as measured by
the Akaike Information Criterion (AIC), was retained for the final
model specification.
For ease of interpretation, the cost attribute was coded
continuously. For the home alternative the out-of-pocket cost
was coded for this variable as $0 or $15 (AU$1 < US$1< Euro
0.8 at 1st July 2012). Due to the potential for out of pocket costs in
the Australian health system, the inclusion of a possible out of
pocket cost in the design was considered to be realistic for the
home-based CHF-MP. For the travel alternative, travel compen-
sation ($0 or $15) was converted to a travel cost adjusted for the
sample’s mean self-reported travel cost ($10.82) and coded for this
variable as $-4.18 (where a $15 voucher was provided) or $10.82
(where the participant was told they had to pay their own travel
costs). All other attributes were effects coded in the model [21].
To address the second objective, WTP for program delivery was
estimated using two different methods: indirectly from the LC
model of choice responses using the compensating variation
method [22], and using direct responses to a dichotomous WTP
bidding question in the survey. In the bidding approach,
participants were asked to indicate their WTP using a dichotomous
response (yes/no) to a bid, with the bid varied in a ping pong
fashion according to a bidding algorithm until the respondent
stated they would not pay the offered amount. At this point the last
value the respondent agreed they would pay was used to estimate
the mean and median marginal WTP for the preferred delivery
mode. To minimise any starting point bias [23], participants were
randomised to a starting bid of either AU$10 or AU$20. The use
of two methods to estimate WTP allows data triangulation and
potentially an increased level of confidence around the findings.
Results
Of the 126 trial participants invited to participate in the DCE,
97 were judged by the research nurse to be cognitively able and
agreed, representing a 77% response rate. Two participants who
Table 1. Attributes and levels.
Attribute Description and levels
How often you see
the nurse
N Once every week: You see the nurse once each week
N Once every month: You see the nurse once each month
Continuity of contact N Same nurse: You usually see the same nurse each time
N Different nurse: You often see a different nurse each time
Cost to you each time
you see the nurse
[For home program]: This describes the cost to you personally of seeing the nurse, which you would be asked to pay from your own
pocket.
N $0: There is no charge each time you see the nurse.
N $15: We would like you to imagine you are asked to pay $15 from your own pocket each time you see the nurse. You will not have to
pay this amount. This is just a way of finding out how strongly you feel about heart failure management programs.
[For clinic program]: If you see a nurse at a clinic, you might have to pay travel costs to get to the clinic (for example, you might have to
pay for a bus, taxi, or car-parking).
N You pay: You pay your own costs to travel to the clinic each time you see the nurse.
N $15 voucher: We would like you to imagine that you are given a $15 voucher to pay for your travel costs each time you see the nurse.
If you see a nurse at home, you would not need to pay travel costs ($0), as you would not need to travel to see the nurse.
Telephone advice
service
N Yes: You have access to a telephone number which you can call to speak to a nurse if you need advice about your heart failure. There is
no additional charge for this service.
N No: You do not have access to this telephone service.
Group education class N Yes: You are offered group education classes where you can learn more about your heart failure. These are run at a local clinic and
usually involve some information sessions provided by nurses, doctors, a pharmacist, a dietician, and a physiotherapist. Often, these
programs provide an opportunity to meet other people with heart failure. There is no additional charge for this service.
N No: You do not have the opportunity to attend group education classes.
doi:10.1371/journal.pone.0058347.t001
Figure 1. Sample choice set.
doi:10.1371/journal.pone.0058347.g001
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were not randomised to a survey version in error and four
participants with missing choice data were excluded; thus, the
choice model was based on 455 choice observations (5 choice sets
from each of the 91 respondents).
Table 2 summarises the respondent characteristics. With the
exception of more male individuals, participants in the preference
survey were typical of CHF patients. Their socio-demographic and
clinical profile did not significantly differ between trial groups or
from the remainder of surviving patients in the study (p.0.05;
comparative data not available for income, employment or health
insurance status). Respondents were more cognitively intact than
non-participants (p,0.05) likely reflecting the inclusion require-
ments for the preference survey. Participants were approximately
evenly distributed between each trial arm (51.6% clinic, 48.4%
home), DCE block, and WTP starting bid. The mean estimated
travel cost from home to clinic reported by all participants
(regardless of whether they were receiving a clinic or home based
service) was $10.82 (SD 11.68).
When asked to indicate a direct preference between a clinic or
home-based service, 48 (52.7%) participants stated they would
prefer clinic and 43 (47.3%) would prefer home. However, there
was no observed association between study arm and preference
(53% of those in the clinic arm preferred home and 59% of those
in the home arm preferred clinic (p = 0.24). The slightly greater
preference overall for clinic-based services was reflected in the raw
data observation of a higher proportion of respondents always
choosing the clinic alternative across the five choice sets regardless
of the level of the other DCE attributes (24, 26.4%), compared to
respondents that always chose the home alternative (20, 22.0%).
An exploratory analysis to identify associations between whether
or not a respondent always chose the same alternative across all
five choice sets and their clinical and socio-demographic
characteristics (as listed in Table 2) suggested those that were
married or living with a partner were less likely to have a dominant
preference for home or clinic and more likely to trade between
home and clinic based on the levels of the other attributes
(p = 0.03). No other significant observations were observed for the
raw data.
Preferences for Program Characteristics
For the LC model, only age, being married/living with a partner
and household income met the criteria for inclusion in the final LC
model. None of the other tested characteristics, including study
arm (clinic or home), were close to significance in predicting
preference class membership (p.0.1).
The results of the LC model are summarised in Table 3. The
model represents a reasonable fit for the choice data (pseudo-R2 of
0.296) [24]. Participants displayed two distinct classes of prefer-
ence for a CHF-MP, with the program attributes having a quite
different impact on preferences in each class. On average,
members of class one preferred clinic over home, access to group
education classes, and lower cost programs (p,0.05). However,
they were indifferent to the frequency of appointments or the
availability of a phone advice service. Conversely, members of
class two preferred home over clinic, monthly rather than weekly
visits, and access to a phone advice service (p,0.05), but were
indifferent to accessing group education classes and notably were
not sensitive to cost. Continuity of nurse contact was consistently
important with both classes preferring to see the same nurse at
each visit (p,0.05).
On average, each participant had a probability of 0.56 of
belonging to class one and 0.44 of belonging to class two. Thus,
the choice model predicted similar preference proportions to that
stated directly by participants, supporting model validity. There
was a trend for participants who were younger, married or living
with a partner, or who had a higher household income, to be more
likely to belong to class one (and therefore to prefer clinic) relative
to class two; however, this trend failed to reach statistical
significance (p = 0.09, 0.11, 0.07 respectively).
Willingness to Pay for Preferred Program Delivery
For each latent preference class in the LC model of choice
responses, the WTP was estimated for a move from a state where
only the least preferred alternative was available (home for class 1
and clinic for class 2), to a state where a choice was available
between clinic or home (with levels of the other attributes held
constant). For each member of class 1, an average welfare gain of
$9.07 was associated with the provision of a clinic program for
each visit. The validity of estimating WTP for members of class 2
is compromised by the lack of significance of the cost parameter
for this class in the LC model. Nevertheless, an indicative estimate
from the LC model is that each member of class 2 would be willing
to pay $105.40 for having a home option available.
In comparison, using the dichotomous bidding approach, those
who indicated they would prefer a clinic program were willing to
pay on average AU$27.28 (median $20.00, IQR $10.00–$30.00)
more for a clinic visit rather than home visit. The participants who
indicated they would prefer a home program were willing to pay
on average AU$15.43 (median $15.00, IQR $8.75–$20.00) more
for a home visit rather than clinic visit.
Discussion
Despite the clear relevance of patient preferences to service
design and delivery, few studies have explored the preferences or
opinions of patients around the delivery of CHF-MPs. This study
provides an example of how the inclusion of a preference study
alongside a clinical trial can add an additional dimension to the
evaluation of competing CHF-MPs; it shows the acceptability of
different program characteristics to patients and elucidates the
nuances of patient preferences for program provision. Based on
a large subset of patients enrolled in the WHICH? Trial [9,10],
this study found preferences for the delivery of a program via
a clinic or home based setting were largely dichotomised;
approximately half of participants expressed a strong preference
for either a clinic or home based program, with the other half
having less strong preferences for the place of delivery. Overall, the
principal finding suggests that two distinct program models would
deliver the preferred services to the vast majority of patients with
CHF. A home-based model with remote services (such as
telephone advice) is more likely to suit older patients, those who
live alone, and those with a lower household income; and a clinic-
based model with on-site services such as group education classes is
more likely to suit those who are more socially active and
wealthier.
Regardless of the program design, the importance of continuity
of staff contact was shown. Although this is aligned with previous
research [7], to our knowledge this is the first time the importance
of this characteristic has been objectively determined with
preference weights in a DCE format. Having continuity of staff
was almost as important for respondents as access to group
education (class 1) or telephone advice (class 2). Those with less
strong preferences were willing to trade between a home or clinic-
based program dependent on the other characteristics provided by
the program. If individuals who have a strong preference for
a program could be identified, clinicians could focus on targeting
these individuals in order to provide patients with their preferred
choice of delivery. An exploratory analysis of our raw data suggests
Patient Preferences for CHF Management Programs
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Table 2. Respondent characteristics by trial randomisation group.
Respondent
characteristics
Clinic-based
CHF-MP
(N=47)
Home-based
CHF-MP
(N=44)
All
respondents
(N=91*)
At entry to WHICH? trial: Site (for WHICH?){ New South Wales 23 (48.9%) 18 (40.9%) 41 (45.1%)
Queensland 10 (21.3%) 8 (18.2%) 18 (19.8%)
South Australia 14 (29.8%) 18 (38.3%) 32 (35.2%)
Age Mean (SD) Yrs 71.00 (14.13) 70.11 (11.18) 70.57 (12.72)
Gender Male 34 (72.3%) 32 (72.7%) 66 (72.5%)
Ethnicity European/Caucasian 43 (91.5%) 42 (95.5%) 85 (93.4%)
Aboriginal/Torres Strait Islander 2 (4.3%) 1 (2.3%) 3 (3.3%)
Asian 2 (4.3%) 1 (2.3%) 3 (3.3%)
Marital status Married/with partner 20 (42.6%) 17 (38.6%) 37 (40.7%)
Widowed 11 (23.4%) 6 (13.6%) 17 (18.7%)
Separated/Divorced 10 (21.3%) 11 (25%) 21 (23.1%)
Never married 6 (12.8%) 10 (22.7%) 16 (17.6%)
Highest education Primary school 6 (13.0%) 9 (21.4%) 15 (17.0%)
Secondary school 18 (39.1%) 19 (45.2%) 37 (42.0%)
TAFE/Trade school 16 (34.8%) 7 (16.7%) 23 (26.1%)
Degrees, Diploma or Graduate Certificate 6 (13.0%) 7 (16.7%) 13 (14.8%)
Distance from home to clinic Mean (SD) kms 9.23 (10.32) 10.07 (15.12) 9.64 (12.80)
HF duration prior to WHICH?
trial enrolment
Mean (SD) mths 34.47 (55.03) 36.27 (70.99) 35.34 (62.90)
At completion of DCE
survey (final follow-up):
Main source of income (self-) Employed 4 (8.9%) 6 (13.6%) 10 (11.2%)
Supported by family member 2 (4.4%) 0 (0%) 2 (2.2%)
Pension from Government 33 (73.3%) 32 (72.7%) 65 (73.0%)
Self-funded retiree 4 (8.9%) 3 (6.8%) 7 (7.9%)
Other 2 (4.4%) 3 (6.8%) 5 (5.6%)
Income (annual household, AU$) Up to $25,000 28 (68.3%) 31 (79.5%) 59 (73.8%)
$25,0001–$50,000 6 (14.6%) 5 (12.8%) 11 (13.8%)
$50,0001–$75,000 2 (4.9%) 2 (5.1%) 4 (5.0%)
$75,0001–$100,000 3 (7.3%) 1 (2.6%) 4 (5.0%)
$100,0001–$125,000 1 (2.4%) 0 (0%) 1 (1.3%)
.$125,000 1 (2.4%) 0 (0%) 1 (1.3%)
Health Insurance Hospital +/2 Extras 15 (31.9%) 13 (29.5%) 28 (31.5%)
MOCA Mean (SD) 25.14 (3.61) 25.26 (3.38) 25.20 (3.48)
NYHA II 33 (70.2%) 35 (79.5%) 68 (74.7%)
III 14 (29.8%) 9 (20.5%) 23 (25.3%)
EQ5D Mean (SD) 0.76 (0.18) 0.75 (0.22) 0.75 (0.20)
Estimated travel cost to clinic Mean (SD) $ 12.88 (13.66) 8.63 (8.63) 10.82 (11.68)
Survey version
completion:
DCE block 1 9 (19.1%) 11 (25.0%) 20 (22.0%)
2 11 (23.4%) 14 (31.8%) 25 (27.5%)
3 14 (29.8%) 12 (27.3%) 26 (28.6%)
4 13 (27.7%) 7 (15.9%) 20 (22.0%)
WTP starting bid $10 21 (44.7%) 25 (56.8%) 46 (50.6%)
$20 26 (55.4%) 19 (43.2%) 45 (49.4%)
DCE discrete choice experiment; WTP willingness to pay; MOCA Montreal Cognitive Assessment Tool; NYHA New York Heart Association; TAFE Tertiary and Further
Education Institution.
*Proportion (%) refers to valid cases. Missing responses excluded from denominator: 56EQ5D, 26Employment, 116Income, 26Insurance, 56MOCA, 36Education
status.
{A greater number of study participants had completed follow-up for the Queensland site prior to ethical approval being granted for the preference study and were
therefore not invited to participate in the preference study; this explains the higher number completing from the other two sites.
doi:10.1371/journal.pone.0058347.t002
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that those that are not married or living with a partner are more
likely to have strong preferences for either a home or clinic-based
program and could be targeted. However, the relatively small
sample size may have limited our test for association and further
studies exploring this association are required if a predictive model
is to be developed.
A strong program preference might be expected given the
nature of the trial and exposure to one or the other mode of CHF-
MP. Interestingly though, we did not observe an association
between preference for a clinic or home based program and
participant allocation in the parent trial. The data from this
preference study provide important additional information when
interpreting the major findings of the WHICH? Trial – that these
commonly applied forms of CHF-MP are similar in terms of
event-free survival from re-hospitalisation or death (the primary
endpoint), but may differ in respect to duration of recurrent
hospital stay and, critically, in terms of economic considerations,
with total health care expenditure in favour of the home-based
intervention [10]. It is important to note that during the survey,
participants were not aware of potential differences in respect to
health outcomes.
This preference study can also be used to value different CHF-
MPs within an economic framework. In theory, both the DCE and
direct WTP methods applied in this study can provide an estimate
of the economic value or welfare gain associated with program
provision from a patient perspective. The directly elicited marginal
WTP using a bidding algorithm provided a slightly higher estimate
for a clinic visit in those who preferred clinic (median AU$20, IQR
$10–$30) than for a home visit in those who preferred home
(median AU$15, IQR $8.75–$20.00). Conversely, the DCE
findings suggest substantially greater value for a home rather than
clinic program in the cohort who responded. However, there is
considerable uncertainty around the estimated WTP value for
home programs for several reasons. Firstly, the cost attribute for
class 2 did not reach significance, resulting in a low level of
precision for the estimate. Further, the absolute size of the WTP
value in this population, who were generally of low income and
not employed, was surprisingly large. Even though the two WTP
methods technically estimated different concepts (i.e. to estimate
WTP for home, the DCE method estimates a WTP for having an
option of home or clinic rather than being forced to have a clinic
program, and the bidding method estimates a marginal WTP for
home over clinic), a large difference in WTP between the two
methods as was observed for the home-based program would seem
unexpected.
Estimating WTP in the context of health care, where services
are subject to public provision and patients may not ordinarily
have to pay for services out of pocket, is challenging. Previous
studies have reported biases with estimates for WTP directly
elicited from respondents [23], and non-attendance to the cost
attribute included in choice experiments [25]. It would seem
possible that participants in the current study were not prepared to
consider the possibility of having to pay for a home visit which
would conventionally be provided at no cost in a public hospital
service. It is also possible that on average membership of class 2,
which was weakly associated with older age and a lower household
income, may be correlated with a lower ability to understand the
DCE task and the hypothetical concept of paying for a service.
Nevertheless, estimating the value of the characteristics of a health
service beyond those that relate directly to health outcomes is an
important consideration in welfare maximisation.
Despite the uncertainty in the WTP estimates provided by this
study, it is unlikely that the value derived from patients for their
preferred home-based or clinic-based service would offset the
substantial cost advantage to the health system in favour of home-
based programs reported by the WHICH? Trial (median cost per
day follow-up $52 (95%CI: $17–$140) for clinic, $34 (95%CI:
$13–$81) for home, difference in medians $18 per day p = 0.034)
Table 3. Latent class model coefficients.
Variable Referent Class 1 Class 2
Utility parameters in
latent class
Constant for home (clinic) ***21.731 *** 2.101
Weekly frequency (monthly) 0.020 ***20.515
Same nurse (different) ** 0.232 * 0.158
Cost ***20.068 20.016
Access phone advice (no access) 0.063 **0.196
Access group education (no access) **0.334 0.160
Class probability model Constant * 2.865 0 (fixed)
Age *20.036 0 (fixed)
Married/Living with partner (single, divorced or widowed) 0.429 0 (fixed)
Household income
(.AU$50,000)
(#$50,000) * 0.001 0 (fixed)
Average class probability 0.558 0.442
Model statistics No. observations 455
LL 2222.105
AIC 1.047
Pseudo R2 0.296
AIC Akaike Information Criterion; LL Log Likelihood.
***p,0.01.
**p,0.05.
*p,0.1.
doi:10.1371/journal.pone.0058347.t003
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[10]. As noted earlier, the DCE reported here did not test whether
spending fewer days in hospital, as reported by the WHICH? Trial
to be a beneficial outcome favouring home-based programs [10],
would change the choices people made based on characteristics of
survey delivery. Therefore, it is possible that some individuals
preferring clinic-based delivery may change their preference if
provided with this information, and WTP for a home-based
program may have been underestimated. The findings of this
preference sub-study and the parent trial taken together would
suggest that overall, if only one service can be provided, a home-
based program is likely to provide the greatest societal value.
Perceived treatment burden has been associated with poorer
self-reported health outcomes and reduced treatment adherence
[26,27]. Since it is the perception of treatment burden that is
important, an understanding and active consideration of patient
preferences is likely to be an important intermediary in reducing
treatment burden and its sequelae, particularly in the management
of chronic diseases with high levels of co-morbidity such as CHF
[26]. Therefore, not withstanding the apparent economic
advantages associated with the home-based program, flexibility
of program delivery is an important goal. Inflexible programs may
lose their economic advantage and lead to suboptimal health
outcomes if they do not meet patient preference and as
a consequence result in high treatment burden and/or non-
compliance.
The DCE in this study was undertaken at the end of a trial
when all participants had experienced either a clinic or home-
based program. Although we tested for an association between the
trial arm and preference structure, and did not identify such an
association, it is possible that the preferences of treatment naı¨ve
patients would be different. The generalisability of this preference
study may potentially be limited by the sample. Whilst broadly
reflecting the characteristics of surviving members of the wider
trial cohort, the members of the preference sample were
cognitively intact, the majority were male, and most had relatively
mild symptoms of heart failure at the time they were surveyed.
Further, trial participants may have been more likely than non-
trial participants to accept the possibility of being allocated to
either a clinic or home-based program [9]. Therefore, it is unclear
how generalisable the findings of the preference survey are to the
broader population of CHF patients, and further research is
needed to assess the preferences of different CHF populations.
Finally, a combination of the sample size and relatively high
proportion of participants who were unwilling to trade between
programs may limit the power of the analysis to test associations
between respondent characteristics and class membership.
The strengths of this study include a patient-centred focus and
the multiple methods (direct and indirect) that were employed to
assess preferences and WTP. Whilst discrete choice methods have
become popular to assess patient preferences for health care [14],
this study represents a novel application of the DCE to assess
patient preferences for a disease MP. The characteristics of
delivery of a CHF-MP are important considerations for both
health care providers and patients alike. This study shows that the
acceptability of a CHF-MP to patients is affected by how it is
delivered. To optimise the value that society receives from these
programs and arguably patient adherence, it is vital to consider
patient preferences for program delivery in addition to more
conventional measures of clinical benefits and health system costs.
Further research into patient preferences for programs to assist
with the management of cardiovascular disease including heart
failure and in particular hybrid models would aid our un-
derstanding of optimal service design. Incorporation of discrete
choice methods to evaluate service delivery more broadly and
prospectively would support a greater understanding of patient
preferences in the management of CHF and other burdensome
conditions.
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